The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

EMBO Journal

Volumn 21, Issue 19, 2002, Pages 5017-5025

  Scarselli, Elisa ^a   Ansuini, Helenia ^a   Cerino, Raffaele ^a   Roccasecca, Rosa Maria ^b   Acali, Stefano ^a   Filocamo, Gessica ^a   Traboni, Cinzia ^a   Nicosia, Alfredo ^a   Cortese, Riccardo ^a   Vitelli, Alessandra ^a  

^a IRBM   (Italy)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Hepatitis C virus; Hypervariable region 1; Scavenger receptor class B type I; Second envelope glycoprotein

Indexed keywords

CD36 ANTIGEN; CD81 ANTIGEN; ENVELOPE PROTEIN; GLYCOPROTEIN E; MONOCLONAL ANTIBODY; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN; SCAVENGER RECEPTOR; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; EMBRYO; FEMALE; GENE DELETION; GENE MUTATION; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; VIRUS ISOLATION; WILD TYPE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD36; CARCINOMA, HEPATOCELLULAR; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; FLOW CYTOMETRY; HEPACIVIRUS; HUMANS; LEUKEMIA, T-CELL; LIVER NEOPLASMS; MEMBRANE PROTEINS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; SCAVENGER RECEPTORS, CLASS B; TUMOR CELLS, CULTURED;

ANIMALIA; HEPATITIS C VIRUS;

EID: 18644378971     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf529     Document Type: Article

References (50)

1. Acton, S.L., Scherer, P.E., Lodish, H.F. and Krieger, M. (1994) Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem., 269, 21003-21009.
2. Acton, S., Rigotti, A., Landschulz, K.T., Xu, S., Hobbs, H.H. and Krieger, M. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science, 271, 518-520.
3. Agnello, V., Abel, G., Elfahal, M., Knight, G.B. and Zhang, Q.X. (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl Acad. Sci. USA, 96, 12766-12771.
4. Allander, T., Forns, X., Emerson, S.U., Purcell, R.H. and Bukh, J. (2000) Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. Virology, 277, 358-367.
5. Babitt, J., Trigatti, B., Rigotti, A., Smart, E.J., Anderson, R.G., Xu, S. and Krieger, M. (1997) Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem., 272, 13242-13249.
6. Bartenschlager, R. and Lohmann, V. (2001) Novel cell culture systems for the hepatitis C virus. Antiviral Res., 52, 1-17.
7. Bergelson, J.M., Chan, M., Solomon, K.R., St John, N.F., Lin, H. and Finberg, R.W. (1994) Decay-accelerating factor (CD55), a glycosyl-phosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl Acad. Sci. USA, 91, 6245-6249.
8. Berger, E.A., Murphy, P.M. and Farber, J.M. (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu. Rev. Immunol., 17, 657-700.
9. Calvo, D. and Vega, M.A. (1993) Identification, primary structure and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J. Biol. Chem., 268, 18929-18935.
10. Calvo, D., Gomez-Coronado, D., Lasuncion, M.A. and Vega, M.A. (1997) CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL and VLDL) and modified (OxLDL and AcLDL) lipoproteins. Arterioscler. Thromb. Vasc. Biol., 17, 2341-2349.
11. Calvo, M. and Enrich, C. (2000) Biochemical analysis of a caveolae-enriched plasma membrane fraction from rat liver. Electrophoresis, 21, 3386-3395.
12. Cerino, A., Meola, A., Segagni, L., Furione, M., Marciano, S., Triyatni, M., Liang, T.J., Nicosia, A. and Mondelli, M.U. (2001) Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles. J. Immunol., 167, 3878-3886.
13. Choo, Q.L., Kuo, G., Ralston, R., Weiner, A., Chien, D., Van Nest, G., Han, J., Berger, K., Thudium, K., Kuo, C. and et al. (1994) Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl Acad. Sci. USA, 91, 1294-1298.
14. Clayton, R.F., Owsianka, A., Aitken, J., Graham, S., Bhella, D. and Patel, A.H. (2002) Analysis of antigenicity and topology of e2 glycoprotein present on recombinant hepatitis C virus-like particles. J. Virol., 76, 7672-7682.
15. Empig, C.J. and Goldsmith, M.A. (2002) Association of the caveola vesicular system with cellular entry by filoviruses. J. Virol., 76, 5266-5270.
16. Farci, P., Alter, H.J., Wong, D.C., Miller, R.H., Govindarajan, S., Engle, R., Shapiro, M. and Purcell, R.H. (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl Acad. Sci, USA, 91, 7792-7796.
17. Farci, P., Shimoda, A., Wong, D., Cabezon, T., De Gioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H.J. and Purcell, R.H. (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl Acad. Sci. USA, 93, 15394-15399.
18. Febbraio, M., Hajjar, D.P. and Silverstein, R.L. (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation and lipid metabolism. J. Clin. Invest., 108, 785-791.
19. Flint, M., Maidens, C., Loomis-Price, L.D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S. and McKeating, J.A. (1999) Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol., 73, 6235-6244.
20. Flint, M., Dubuisson, J., Maidens, C., Harrop, R., Guile, G.R., Borrow, P. and McKeating, J.A. (2000) Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J. Virol., 74, 702-709.
21. Forns, X., Thimme, R., Govindarajan, S., Emerson, S.U., Purcell, R.H., Chisari, F.V. and Bukh, J. (2000) Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc. Natl Acad. Sci. USA, 97, 13318-13323.
22. Fried, M.W. and Hoofnagle, J.H. (1995) Therapy of hepatitis C. Semin. Liver Dis., 15, 82-91.
23. Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S. and Shimotohno, K. (1991) Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem. Biophys. Res. Commun., 175, 220-228.
24. Kahne, T. and Ansorge, S. (1994) Non-radioactive labelling and immunoprecipitation analysis of leukocyte surface proteins using different methods of protein biotinylation. J. Immunol. Methods, 168, 209-218.
25. Korenaga, M., Hino, K., Katoh, Y., Yamaguchi, Y., Okuda, M., Yoshioka, K. and Okita, K. (2001) A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization. J. Viral Hepat., 8, 331-340.
26. Krieger, M. (2001) Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J. Clin. Invest., 108, 793-797.
27. Lagging, L.M., Meyer, K., Westin, J., Wejstal, R., Norkrans, G., Lindh, M. and Ray, R. (2002) Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients. J. Infect. Dis., 185, 1165-1169.
28. Manes, S. et al. (2000) Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep., 1, 190-196.
29. Matsuura, Y. et al. (2001) Characterization of pseudotype VSV possessing HCV envelope proteins. Virology, 286, 263-275.
30. McHutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., Goodman, Z.D., Ling, M.H., Cort, S. and Albrecht, J.K. (1998) Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med., 339, 1485-1492.
31. Meola, A. et al. (2000) Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J. Virol., 74, 5933-5938.
32. Mondelli, M.U., Cerino, A., Segagni, L., Meola, A., Cividini, A., Silini, E. and Nicosia, A. (2001) Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain? Antiviral Res., 52, 153-159.
33. Norkin, L.C., Anderson, H.A., Wolfrom, S.A. and Oppenheim, A. (2002) Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol., 76, 5156-5166.
34. Penin, F., Combet, C., Germanidis, G., Frainais, P.O., Deleage, G. and Pawlotsky, J.M. (2001) Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J. Virol., 75, 5703-5710.
35. Petracca, R. et al. (2000) Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol., 74, 4824-4830.
36. Pileri, P. et al. (1998) Binding of hepatitis C virus to CD81. Science, 282, 938-941.
37. Puntoriero, G. et al. (1998) Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J., 17, 3521-3533.
38. Robertson, B. et al. (1998) Classification, nomenclature and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch. Virol., 143, 2493-2503.
39. Rosa, D. et al. (1996) A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl Acad. Sci. USA, 93, 1759-1763.
40. Scarselli, E., Cerino, A., Esposito, G., Silini, E., Mondelli, M.U. and Traboni, C. (1995) Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J. Virol., 69, 4407-4412.
41. Silver, D.L., Wang, N., Xiao, X. and Tall, A.R. (2001) High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J. Biol. Chem., 276, 25287-25293.
42. Sobolev, B.N., Poroikov, V.V., Olenina, L.V., Kolesanova, E.F. and Archakov, A.I. (2000) Comparative analysis of amino acid sequences from envelope proteins isolated from different hepatitis C virus variants: possible role of conservative and variable regions. J. Viral Hepat., 7, 368-374.
43. Strader, D.B. and Seeff, L.B. (2001) Hepatitis C: a brief clinical overview. ILAR J., 42, 107-116.
44. Triyatni, M., Vergalla, J., Davis, A.R., Hadlock, K.G., Foung, S.K. and Liang, T.J. (2002) Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology, 298, 124-132.
45. van der Goot, F.G. and Harder, T. (2001) Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin. Immunol., 13, 89-97.
46. Wasley, A. and Alter, M.J. (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis., 20, 1-16.
47. Weiner, A.J. et al. (1991) Sequence variation in hepatitis C viral isolates. J. Hepatol., 13, S6-S14.
48. Yagnik, A.T., Lahm, A., Meola, A., Roccasecca, R.M., Ercole, B.B., Nicosia, A. and Tramontano, A. (2000) A model for the hepatitis C virus envelope glycoprotein E2. Proteins, 40, 355-366.
49. Yancey, P.G., Rodrigueza, W.V., Kilsdonk, E.P., Stoudt, G.W., Johnson, W.J., Phillips, M.C. and Rothblat, G.H. (1996) Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem., 271, 16026-16034.
50. Zhou, Y.H., Shimizu, Y.K. and Esumi, M. (2000) Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro. Virology, 269, 276-283.